Astrana Health
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical...
Latest News
10 days ago · seekingalpha.com
Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call TranscriptAstrana Health, Inc. ( ASTH ) Q3 2026 Earnings Call November 5, 2026 5:30 PM EST Company Participants Brandon Sim - President & CEO Chan Basho - CFO, COO & Corporate Secretary Conference Call Participants Jack Slevin - Jefferies LLC, Research Division Hua Ha - Robert W. Baird & Co. Incorporated, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ryan Langston - TD Cowen, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division David Larsen - BTIG, LLC, Research Division Ryan Daniels - William Blair & Company L.L.C.
11 days ago · marketbeat.com
Astrana Health Q3 Earnings Call HighlightsAstrana Health NASDAQ: ASTH reported record third-quarter revenue and adjusted EBITDA as growth in Medicare Advantage membership and full-risk contracts helped offset declines in Medicaid and exchange enrollment.
11 days ago · zacks.com
Astrana Health, Inc. (ASTH) Q3 Earnings Lag EstimatesAstrana Health, Inc. (ASTH) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.01 per share a year ago.
11 days ago · prnewswire.com
Astrana Health, Inc. Reports Third Quarter 2026 ResultsCompany to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m.
20 days ago · seekingalpha.com
Diamond Hill Small Cap Fund Q3 2026 Portfolio ActivityUtz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health declined during the quarter as selling pressure emerged following a strong first half of 2026. We initiated a position in Bank7, given its highly profitable, branch-light model and recent acquisition of Century Bank, which we believe should meaningfully enhance earnings.
1 month ago · gurufocus.com
Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says UndervaluedOn October 09, 2026, Astrana Health Inc (ASTH) shares rose 4.7% to a current price of $37.55, within a 52-week range of $18.08 to $51.60. This movement reflects
1 month ago · prnewswire.com
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference CallALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2026, after the close of the stock market on Thursday, November 5, 2026.
1 month ago · zacks.com
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates AgainAstrana Health, Inc. (ASTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 months ago · businesswire.com
PRIVACY ALERT: AWKO Law Investigating Astrana Health Data BreachSAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of individuals affiliated with Astrana Health, Inc.'s subsidiary, Astrana Health Management, Inc. Astrana Health, Inc. is a California-based technology-powered healthcare company that operates as a Management Services Organization (MSO). On September 23, 2026, Astrana Health, Inc. disclosed to the Securities and Exchange Commission (“SEC”) that unauthorized ac.
2 months ago · globenewswire.com
Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities LawsNEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ASTH